These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4530864)

  • 1. Enhancing the sensitivity of the SMA profile.
    Krosnick A
    J Med Soc N J; 1974 Nov; 71(11):824-4. PubMed ID: 4530864
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of normal values in multiphasic health screening--introduction of SMA-12/60 autoanalyzer and its application to multiphasic health screening].
    Sasaki T
    Nihon Rinsho; 1971 Sep; 29(9):2048-57. PubMed ID: 5166012
    [No Abstract]   [Full Text] [Related]  

  • 3. [Symposium on multiscreening in diagnosis and medical examination. 2. Problems of normal values].
    Kasuga S
    Rinsho Byori; 1972 Aug; 20(8):534-9. PubMed ID: 4674639
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of abnormal glucose tolerance in Khon Kaen Province and validity of urine stick and fasting blood sugar as screening tools.
    Chaisiri K; Pongpaew P; Tungtrongchitr R; Phonrat B; Kulleap S; Kuhathong C; Sutthiwong P; Intarakhao C; Mahaweerawat U; Khongdee W; Sanchaisuriya P; Saowakontha S; Merkle A; Schelp FP
    J Med Assoc Thai; 1997 Jun; 80(6):363-71. PubMed ID: 9240010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Symposium on multiscreening in diagnosis and medical examination. 4. Significance of data from the SMA-12 in clinical diagnosis].
    Makino H
    Rinsho Byori; 1972 Aug; 20(8):543-6. PubMed ID: 4674641
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost analysis of Wisconsin's program of multiphasic health screening.
    Schwartz TH; Laessig RH; Preizler J
    Health Serv Rep; 1972; 87(6):523-9. PubMed ID: 5045719
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease.
    Heldgaard PE; Olivarius Nde F; Hindsberger C; Henriksen JE
    Diabet Med; 2004 Apr; 21(4):363-70. PubMed ID: 15049940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fasting glucose versus oral glucose tolerance testing in the diagnosis of diabetes mellitus].
    Mollar-Puchades MA; Pallarés-Carratalá V; Navas de Solís MS; Piñón-Sellés F
    Rev Esp Cardiol; 2006 Dec; 59(12):1349-50. PubMed ID: 17194436
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of fasting plasma glucose as a screening test for diabetes mellitus in Singaporean adults.
    Lee CH; Fook-Chong S
    Diabet Med; 1997 Feb; 14(2):119-22. PubMed ID: 9047088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels.
    Succurro E; Marini MA; Grembiale A; Lugarà M; Andreozzi F; Sciacqua A; Hribal ML; Lauro R; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2009 May; 25(4):351-6. PubMed ID: 19319930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reproducibility of Conard's glucose assimilation coefficient in intravenous glucose tolerance test in the hospital].
    Ratzmann KP; Baufeld W
    Z Gesamte Inn Med; 1973 Dec; 28(24):766-70. PubMed ID: 4779140
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution of biochemical values as determined by the Wisconsin multiphasic Screening program 1968-1970.
    Preizler J
    Wis Med J; 1972 Sep; 71(9):214-6. PubMed ID: 5069122
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reproducibility of 50g oral glucose tolerance test under stationary and ambulatory conditions].
    Wüstenberg PW; Naumann G; Kaeding A; Werner P; Dannenberg C; Lotze C; Wilmbusse H; Henning L
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(5):251-8. PubMed ID: 5161461
    [No Abstract]   [Full Text] [Related]  

  • 14. Point-of-care testing as a tool for screening for diabetes and pre-diabetes.
    Rush E; Crook N; Simmons D
    Diabet Med; 2008 Sep; 25(9):1070-5. PubMed ID: 19183312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness and limitations of biohumoral screening tests in periodical health check-ups].
    Manzo F; Di Blasi S; Totaro S
    Lav Um; 1972 Nov; 24(6 Suppl):61-8. PubMed ID: 4680394
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance.
    Di Cianni G; Miccoli R; Volpe L; Lencioni C; Ghio A; Giovannitti MG; Cuccuru I; Pellegrini G; Chatzianagnostou K; Boldrini A; Del Prato S
    Diabet Med; 2005 Jan; 22(1):21-5. PubMed ID: 15606686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auto-analyzer versus Folin-Wu for blood glucose.
    Altendorf JJ; Seasholtz CE
    Trans Kans Acad Sci; 1970; 73(3):394-8. PubMed ID: 5512121
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of glucose, insulin, and C-reactive protein to determine need for glucose tolerance testing.
    Thompson WG; Bergstralh EJ; Slezak JM
    Obes Res; 2003 Aug; 11(8):1027-32. PubMed ID: 12917509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of blood sugar measured by the automatic reductimetric method and by the glucose oxidase method in 211 fasting subjects and 2 hours after oral glucose load].
    Eschwege E; Warnet JM; Patois E; Rosselin GE; Claude JR
    Pathol Biol (Paris); 1972 Feb; 20(3):187-90. PubMed ID: 4553280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.